Laharie D, Bouhnik Y, Vuitton L, Biron A, et al. Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study). Clin Res Hepatol Gastroenterol 2024;48:102483.
PMID: 39448029